Coalition for Epidemic Preparedness Innovations (CEPI). Working to end epidemics & pandemics by developing new vaccines for a safer world.
#100DaysMission
📣A CEPI-funded first-ever Phase II Lassa vaccine trial has been launched by IAVI in Nigeria.
The trial at
@HJFMRI
in Abuja is designed in consultation with partners including
@NCDCgov
and the Nigeria Lassa Vaccine Taskforce.
This week, alongside my
@CEPIvaccines
colleagues, I was in South Africa and saw first-hand the tremendous progress being made in the region toward advancing rapid response vaccine capabilities, helping to strengthen pandemic preparedness.
"Existing techniques for making flu vaccine work really well, but they are slow”
Could mRNA-based flu vaccines be a path forward to fighting a future flu pandemic faster?
@LindaGeddes
reports for
@gavi
⬇️
#Chikungunya
was first identified in Tanzania in 1952 and is now widely distributed across the globe, with millions of people worldwide affected by its increasing prevalence.
Learn more about this disease, including CEPI's work to advance a vaccine ⬇️
The Hantavirus family is known to have a whole range of accomplices, with each viral family member having one or two specific species of rodents acting as its spreading agent. Here’s why Hantaviruses have earned a place on
@CEPIvaccines
’ Viral Most Wanted:
📢 Check out CEPI's ongoing Call for Proposals: Innovations to Prepare for Future Epidemics and Pandemics.
This Call is seeking innovators to speed up development of and equitable access to safe & effective vaccines against epidemic & pandemic viral threats.
⬇️ Find out more ⬇️…
The Hantavirus family is a group of viruses normally carried by rats, mice and other rodents and is known to cause severe disease and trigger deadly outbreaks. Learn more via
@CEPIvaccines
:
Dr Donald Grant stepped up to finish the work of his mentor who died from
#Ebola
.
@CEPIvaccines
’ latest impact story looks at how he is now rebuilding the research programme on
#lassafever
in Sierra Leone: